To evaluate longer-term (5-7 years) outcomes of the twelve (12) subjects treated with AGN1 Femoral LOEP in the clinical study "A Prospective Pilot Evaluation of Percutaneous Osteo-supplementation in the Proximal Femur of Osteoporotic Patients". Performance will be evaluated via medical history evaluation, X-ray, DXA, CT and mobility testing. The study will look at the extent to which the benefits demonstrated in the initial, baseline study were sustained over time. In this manner, it may be possible to determine the rate of change in BMD following the treatment; thereby allowing prediction of the total benefit period. In addition, this longer period of observation allows for further evaluation of the safety profile of the material in osteoporosis patients.
Age range
56 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days
Bone Mineral Density
Timeframe: through study completion, an average of 30 days